{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:46:43Z","timestamp":1791416803217,"version":"4.3.3"},"reference-count":57,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,15]]},"abstract":"<jats:p>Multiple myeloma (MM) is characterized by accumulation and dissemination of malignant plasma cells (PCs) in the bone marrow (BM). Gene expression profiling of 2 MM cell lines (OH-2 and IH-1) indicated that expression of PRL-3, a metastasis-associated tyrosine phosphatase, was induced by several mitogenic cytokines. Cytokine-driven PRL-3 expression could be shown in several myeloma cell lines at both the mRNA and protein levels. There was significantly higher expression of the PRL-3 gene in PCs from patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma (SMM), and myeloma than in PCs from healthy persons. Among 7 MM subgroups identified by unsupervised hierarchical cluster analysis, PRL-3 gene expression was significantly higher in the 3 groups denoted as \u201cproliferation,\u201d \u201clow bone disease,\u201d and \u201cMMSET\/FGFR3.\u201d PRL-3 protein was detected in 18 of 20 BM biopsies from patients with MM. Silencing of the PRL-3 gene by siRNA reduced cell migration in the MM cell line INA-6, but had no detectable effect on proliferation and cell-cycle phase distribution of the cells. In conclusion, PRL-3 is a gene product specifically expressed in malignant plasma cells and may have a role in migration of these cells.<\/jats:p>","DOI":"10.1182\/blood-2007-07-101139","type":"journal-article","created":{"date-parts":[[2007,10,13]],"date-time":"2007-10-13T00:54:03Z","timestamp":1192236843000},"page":"806-815","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":85,"title":["Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells"],"prefix":"10.1182","volume":"111","author":[{"given":"Unn-Merete","family":"Fagerli","sequence":"first","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"},{"name":"Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi U.","family":"Holt","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"},{"name":"Faculty of Technology, S\u00f8r-Tr\u00f8ndelag University College, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toril","family":"Holien","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea K.","family":"Vaatsveen","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[{"name":"Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjartan W.","family":"Egeberg","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[{"name":"Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Waage","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"},{"name":"Hematology, St Olavs University Hospital, Trondheim, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Aarset","sequence":"additional","affiliation":[{"name":"Pathology and Molecular Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yan","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"},{"name":"Pathology and Molecular Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John D.","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundan","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magne","family":"B\u00f8rset","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;"},{"name":"Departments ofImmunology and Transfusion Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111814453469600_B1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2004-01-0037","article-title":"Advances in biology of multiple myeloma: clinical applications.","volume":"104","author":"Hideshima","year":"2004","journal-title":"Blood"},{"key":"2019111814453469600_B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2141.1999.01510.x","article-title":"Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells.","volume":"106","author":"Hjorth-Hansen","year":"1999","journal-title":"Br J Haematol"},{"key":"2019111814453469600_B3","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood.V99.10.3756","article-title":"Interleukin-21 is a growth and survival factor for human myeloma cells.","volume":"99","author":"Brenne","year":"2002","journal-title":"Blood"},{"key":"2019111814453469600_B4","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/sj.onc.1205355","article-title":"Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.","volume":"21","author":"Wang","year":"2002","journal-title":"Oncogene"},{"key":"2019111814453469600_B5","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"2019111814453469600_B6","first-page":"5607","article-title":"PRL-3 expression in metastatic cancers.","volume":"9","author":"Bardelli","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2019111814453469600_B7","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","article-title":"PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.","volume":"66","author":"Fiordalisi","year":"2006","journal-title":"Cancer Res"},{"key":"2019111814453469600_B8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.febslet.2004.03.062","article-title":"Structure of human PRL-3, the phosphatase associated with cancer metastasis.","volume":"565","author":"Kim","year":"2004","journal-title":"FEBS Lett"},{"key":"2019111814453469600_B9","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.1074\/jbc.M312905200","article-title":"Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.","volume":"279","author":"Kozlov","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111814453469600_B10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000078671","article-title":"Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis.","volume":"71","author":"Miskad","year":"2004","journal-title":"Pathobiology"},{"key":"2019111814453469600_B11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4161\/cbt.3.10.1115","article-title":"PRL-3: a phosphatase for metastasis?","volume":"3","author":"Sager","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"2019111814453469600_B12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1065817","article-title":"A phosphatase associated with metastasis of colorectal cancer.","volume":"294","author":"Saha","year":"2001","journal-title":"Science"},{"key":"2019111814453469600_B13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1158\/1535-7163.MCT-05-0248","article-title":"PRL phosphatases as potential molecular targets in cancer.","volume":"4","author":"Stephens","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"2019111814453469600_B14","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1158\/1078-0432.CCR-04-0485","article-title":"High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.","volume":"10","author":"Kato","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2019111814453469600_B15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0002-9440(10)63763-7","article-title":"Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.","volume":"164","author":"Wu","year":"2004","journal-title":"Am J Pathol"},{"key":"2019111814453469600_B16","first-page":"2716","article-title":"PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.","volume":"63","author":"Zeng","year":"2003","journal-title":"Cancer Res"},{"key":"2019111814453469600_B17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome.","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"2019111814453469600_B18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4161\/cbt.3.10.1111","article-title":"Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels.","volume":"3","author":"Guo","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"2019111814453469600_B19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0609.1994.tb00176.x","article-title":"TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.","volume":"53","author":"Borset","year":"1994","journal-title":"Eur J Haematol"},{"key":"2019111814453469600_B20","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/sj.onc.1207386","article-title":"Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.","volume":"23","author":"Ro","year":"2004","journal-title":"Oncogene"},{"key":"2019111814453469600_B21","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1073\/pnas.93.24.13931","article-title":"Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.","volume":"93","author":"Bergsagel","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111814453469600_B22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.","volume":"97","author":"Shou","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111814453469600_B23","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma.","volume":"83","author":"Zhang","year":"1994","journal-title":"Blood"},{"key":"2019111814453469600_B24","doi-asserted-by":"crossref","first-page":"24655","DOI":"10.1074\/jbc.271.40.24655","article-title":"Concomitant expression of hepatocyte growth factor\/scatter factor and the receptor c-MET in human myeloma cell lines.","volume":"271","author":"Borset","year":"1996","journal-title":"J Biol Chem"},{"key":"2019111814453469600_B25","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/1078-0432.CCR-04-1984","article-title":"Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.","volume":"11","author":"Li","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111814453469600_B26","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"key":"2019111814453469600_B27","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma.","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"key":"2019111814453469600_B28","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","article-title":"Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"key":"2019111814453469600_B29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.1993.tb03331.x","article-title":"Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation.","volume":"85","author":"Borset","year":"1993","journal-title":"Br J Haematol"},{"key":"2019111814453469600_B30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.exphem.2006.06.017","article-title":"Chemokines in multiple myeloma.","volume":"34","author":"Aggarwal","year":"2006","journal-title":"Exp Hematol"},{"key":"2019111814453469600_B31","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"2019111814453469600_B32","first-page":"57","article-title":"DNA copy number changes at 8q11\u201324 in metastasized colorectal cancer.","volume":"27","author":"Buffart","year":"2005","journal-title":"Cell Oncol"},{"key":"2019111814453469600_B33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V97.2.516","article-title":"Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells.","volume":"97","author":"Hjertner","year":"2001","journal-title":"Blood"},{"key":"2019111814453469600_B34","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/MCB.14.6.3752","article-title":"PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth.","volume":"14","author":"Diamond","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2019111814453469600_B35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/bbrc.2001.4881","article-title":"Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.","volume":"283","author":"Matter","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111814453469600_B36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/bbrc.1998.8291","article-title":"Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.","volume":"244","author":"Zeng","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111814453469600_B37","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1158\/0008-5472.CAN-04-1976","article-title":"Alterations in vascular gene expression in invasive breast carcinoma.","volume":"64","author":"Parker","year":"2004","journal-title":"Cancer Res"},{"key":"2019111814453469600_B38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjc.6603261","article-title":"Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.","volume":"95","author":"Radke","year":"2006","journal-title":"Br J Cancer"},{"key":"2019111814453469600_B39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03402041","article-title":"Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.","volume":"9","author":"Schwering","year":"2003","journal-title":"Mol Med"},{"key":"2019111814453469600_B40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-004-0563-x","article-title":"The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.","volume":"130","author":"Peng","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"2019111814453469600_B41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2005.12.043","article-title":"Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.","volume":"65","author":"Wallin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019111814453469600_B42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/annonc\/mdl159","article-title":"Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.","volume":"17","author":"Wang","year":"2006","journal-title":"Ann Oncol"},{"key":"2019111814453469600_B43","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","article-title":"Mechanisms of regulation of CXCR4\/SDF-1 (CXCL12) dependent migration and homing in multiple myeloma.","volume":"109","author":"Alsayed","year":"2007","journal-title":"Blood"},{"key":"2019111814453469600_B44","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nri1203","article-title":"Plasma-cell homing.","volume":"3","author":"Kunkel","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2019111814453469600_B45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2006.07.043","article-title":"Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.","volume":"348","author":"Li","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111814453469600_B46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1535-7163.MCT-05-0289","article-title":"Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.","volume":"5","author":"Rouleau","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2019111814453469600_B47","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1158\/1078-0432.CCR-04-2357","article-title":"PRL-3 phosphatase is implicated in ovarian cancer growth.","volume":"11","author":"Polato","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111814453469600_B48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(03)00517-2","article-title":"Enhanced cell cycle progression and down regulation of p21(Cip1\/Waf1) by PRL tyrosine phosphatases.","volume":"202","author":"Werner","year":"2003","journal-title":"Cancer Lett"},{"key":"2019111814453469600_B49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2003-04-1048","article-title":"Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.","volume":"103","author":"Brocke-Heidrich","year":"2004","journal-title":"Blood"},{"key":"2019111814453469600_B50","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood-2003-04-1227","article-title":"Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells.","volume":"102","author":"Croonquist","year":"2003","journal-title":"Blood"},{"key":"2019111814453469600_B51","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1365-2141.1998.00877.x","article-title":"Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.","volume":"102","author":"Carbone","year":"1998","journal-title":"Br J Haematol"},{"key":"2019111814453469600_B52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2006.01.102","article-title":"Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.","volume":"342","author":"Peng","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111814453469600_B53","first-page":"479","article-title":"Human myeloma cells adhere to fibronectin in response to hepatocyte growth factor.","volume":"90","author":"Holt","year":"2005","journal-title":"Haematologica"},{"key":"2019111814453469600_B54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0092-8674(04)00003-0","article-title":"Rho and Rac take center stage.","volume":"116","author":"Burridge","year":"2004","journal-title":"Cell"},{"key":"2019111814453469600_B55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cell biology.","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"2019111814453469600_B56","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/0008-5472.CAN-06-3598","article-title":"PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"2019111814453469600_B57","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1359-6446(02)02438-8","article-title":"Selecting protein tyrosine phosphatases as drug targets.","volume":"7","author":"van Huijsduijnen","year":"2002","journal-title":"Drug Discov Today"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/806\/1221242\/zh800208000806.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/2\/806\/1221242\/zh800208000806.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:45:50Z","timestamp":1574106350000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/2\/806\/103791\/Overexpression-and-involvement-in-migration-by-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-07-101139","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}